Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Name: Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
Published: 2020
License: Public Domain

Kafrelsheikh University · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

t-cells

covid-19, covid 2019, isotretinoin, endosomal toll-like receptor 3, t cells, ifn type1, at1, ace2, alvelestat, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Related documents